Workflow
Maris(MTEK) - 2024 Q4 - Annual Report
MTEKMaris(MTEK)2025-03-28 20:01

Financial Performance - Revenues for the year ended December 31, 2024 were 6,078,953,anincreaseof6,078,953, an increase of 2,047,850 or 51% compared to 4,031,103in2023[264]Grossprofitfor2024was4,031,103 in 2023[264] - Gross profit for 2024 was 3,516,121, representing a gross profit rate of 57.8%, an increase of 1,588,725or821,588,725 or 82% from 1,927,396 in 2023[266] - Net loss for 2024 was 1,233,892,adecreaseof1,233,892, a decrease of 1,475,704 or 54% compared to a net loss of 2,709,596in2023[274]CashFlowandAssetsCashusedinoperatingactivitieswas2,709,596 in 2023[274] Cash Flow and Assets - Cash used in operating activities was 2,219,583 for 2024, a reduction from 3,871,157in2023[285]AsofDecember31,2024,thecompanyhad3,871,157 in 2023[285] - As of December 31, 2024, the company had 2,335,232 in cash and cash equivalents and restricted deposits[283] Backlog and Future Revenues - The backlog as of January 1, 2025, was approximately 9.8million,expectedtocontributetofuturerevenues[281]ExpensesResearchanddevelopmentexpensesfor2024were9.8 million, expected to contribute to future revenues[281] Expenses - Research and development expenses for 2024 were 927,048, a decrease of 127,847or12127,847 or 12% from 1,054,895 in 2023[268] - Sales and marketing expenses increased by 48,646or648,646 or 6% to 923,439 in 2024 compared to 874,793in2023[269]Generalandadministrativeexpenseswere874,793 in 2023[269] - General and administrative expenses were 3,014,378 for 2024, an increase of 87,068or387,068 or 3% from 2,927,310 in 2023[270] Grants and Funding - As of December 31, 2024, the total amount of grants received was approximately 608,000,includingaccumulatedinterest[295]InAugust2022,ajointgrantwithBenGurionUniversitywasapproved,totalingNIS1,314,024(approximately608,000, including accumulated interest[295] - In August 2022, a joint grant with Ben Gurion University was approved, totaling NIS 1,314,024 (approximately 360,303), covering 66% of the project's first-year budget[296] - In June 2023, a grant of NIS 1,209,797 (approximately 331,724)wasapprovedforthefirstyeardevelopmentofananosatelliteplatform,representing50331,724) was approved for the first-year development of a nanosatellite platform, representing 50% of the total budget[297] - The total research and development income recorded for the year ended December 31, 2024, was NIS 1,152,294 (approximately 307,962)[299] - The grant for the second year of the joint project with Ben Gurion University was approved in November 2023, totaling NIS 935,544 (approximately 256,524)[298]EconomicConditionsTheannualrateofinflationinIsraelwas3.2256,524)[298] Economic Conditions - The annual rate of inflation in Israel was 3.2% in 2024 and 3.0% in 2023, with the NIS revaluating against the U.S. dollar by approximately 0.6% in 2024 and 3.1% in 2023[543] Currency and Risk Management - The company does not currently hedge its foreign currency exchange risk but may consider formal currency hedging transactions in the future[541] - The company anticipates that a significant portion of its expenses will continue to be denominated in NIS, which may impact results if the U.S. dollar fluctuates significantly against the NIS[539] - The company does not believe that off-balance sheet arrangements will materially affect its financial condition or results of operations[299] Intellectual Property - The company has not utilized the intellectual property developed with governmental grants in any products since 2013[295] Credit Facilities - The company entered into a 4 million credit line agreement on March 26, 2025, secured by all assets[293]